NCT07153068
- Conditions
- Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
9,963 public trials
2,020 recruiting studies
Immunoproliferative Disorders trial results
Recruiting
To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT
NCT07280494
- Conditions
- CD7+ T-ALL/LBL, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Peking University People's Hospital Beijing, China
NCT06518551
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +18 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT07179679
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
- Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China
- Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
- The Affiliated Hospital of Chengde Medical College Chengde, Hebei, China
NCT05602363
- Conditions
- B-cell Malignancy, Blood Protein Disorders, Cardiovascular Diseases, +34 more
- Locations
-
- UC Irvine Health Orange, California, United States
- Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Northwestern Memorial Hospital Chicago, Illinois, United States
NCT06251076
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +18 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
NCT05977673
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
- Locations
-
- A.O. SS. Antonio e Biagio e Cesare Arrigo, S.C. Ematologia Alessandria, IT, Italy
- Divisione di Oncologia e dei Tumori immuto-correlati, Centro Di Riferimento Oncologico Di Aviano Aviano, Italy
- Istituto di Ematologia L. e A. Seràgnoli, AOU Policlinico S. Orsola-Malpighi Bologna, Italy
- SC Ematologia, Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia Brescia, Italy
NCT06803693
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Ruijin Hospital, Shanghai JiaoTong University School of Medicine Shanghai, Shanghai Municipality, China
Recruiting
Zanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma
NCT07270835
- Conditions
- B Cell Lymphoma, Hemic and Lymphatic Diseases, Hemophagocytic Lymphohistiocytosis, +12 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
NCT07268846
- Conditions
- Blood Protein Disorders, Breast Diseases, Breast Neoplasms, +33 more
- Locations
-
- A.C.Camargo Cancer Center São Paulo, Brazil